- Home
- SNN vs FMS Comparison
SNN vs FMS Comparison
Compare SNN & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNN
- FMS
- Stock Information
- Founded
- SNN 1856
- FMS 1996
- Country
- SNN United Kingdom
- FMS Germany
- Employees
- SNN N/A
- FMS N/A
- Industry
- SNN Industrial Specialties
- FMS Misc Health and Biotechnology Services
- Sector
- SNN Health Care
- FMS Health Care
- Exchange
- SNN Nasdaq
- FMS Nasdaq
- Market Cap
- SNN 12.3B
- FMS 14.4B
- IPO Year
- SNN 1999
- FMS 1996
- Fundamental
- Price
- SNN $28.17
- FMS $24.75
- Analyst Decision
- SNN Hold
- FMS Hold
- Analyst Count
- SNN 3
- FMS 1
- Target Price
- SNN $27.00
- FMS $25.00
- AVG Volume (30 Days)
- SNN 730.6K
- FMS 336.9K
- Earning Date
- SNN 02-25-2025
- FMS 05-06-2025
- Dividend Yield
- SNN 2.66%
- FMS 2.56%
- EPS Growth
- SNN 56.15
- FMS 7.65
- EPS
- SNN 0.47
- FMS 1.89
- Revenue
- SNN $5,810,000,000.00
- FMS $20,018,541,263.00
- Revenue This Year
- SNN $6.42
- FMS $5.05
- Revenue Next Year
- SNN $5.03
- FMS $3.90
- P/E Ratio
- SNN $29.78
- FMS $25.99
- Revenue Growth
- SNN 4.70
- FMS N/A
- 52 Week Low
- SNN $23.65
- FMS $17.93
- 52 Week High
- SNN $31.72
- FMS $25.25
- Technical
- Relative Strength Index (RSI)
- SNN 50.08
- FMS 57.12
- Support Level
- SNN $27.89
- FMS $24.34
- Resistance Level
- SNN $28.54
- FMS $25.11
- Average True Range (ATR)
- SNN 0.42
- FMS 0.42
- MACD
- SNN -0.18
- FMS 0.05
- Stochastic Oscillator
- SNN 15.81
- FMS 83.10
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.